positive alternative, page-4

Tony

If you want to go off to talk-up early phase PRR clinical data, feel free

Everyone knows that story back-to-front and no one argues that the early results are good on the science side of PRR's business

As this is a stock forum, and as we tend to also concern ourselves with stock valuations, and here particularly the factors affecting the PRR SP, I also like to look at the realities of the commercial side of the business, and like to see management fulfill what they keenly talked-up for many months namely, the value-add to be gained from a nasdaq listing - but on this issue no one really knows the full story is atm, thus why I keep a focus on it, until all the market receives on this issue, the same detailed information we already enjoy coming from the science side of the business

Otherwise if I drive you "crazy" Tony, just hit Ignore my good man - HC created it for a reason you know - and to save your sanity on this occassion it seems


good luck